All lobbying filings

ONMESSAGE PUBLIC STRATEGIES

ONMESSAGE PUBLIC STRATEGIES filed a Q3 report for NEUROTECH PHARMACEUTICALS INC. on October 20, 2026, reporting $50,000 in lobbying income.

Lobbying for NEUROTECH PHARMACEUTICALS INC. · Biotech company

All filings by ONMESSAGE PUBLIC STRATEGIES · Everything NEUROTECH PHARMACEUTICALS INC. has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 20, 2026

Income

$50,000

What the client paid this registrant for the period.

Client based in

Rhode Island

Official filing document

Government bodies contacted 1

Veterans Affairs, Dept of (VA)

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Pharmacy

Issues related to drug development, drug pricing and VA Pharmacy Benefits Management (no specific legislation).

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.